553 related articles for article (PubMed ID: 15191952)
21. Influence of HLA-DP mismatches on primary MLR responses in unrelated HLA-A, B, DR, DQ, Dw identical pairs in allogeneic bone marrow transplantation.
Cesbron A; Moreau P; Milpied N; Muller JY; Harousseau JL; Bignon JD
Bone Marrow Transplant; 1990 Nov; 6(5):337-40. PubMed ID: 1981326
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of pretransplant donor anti-recipient cytotoxic and helper T lymphocyte responses as correlates of acute graft-vs.-host disease and survival after unrelated marrow transplantation.
Pei J; Martin PJ; Longton G; Masewicz S; Mickelson E; Petersdorf E; Anasetti C; Hansen J
Biol Blood Marrow Transplant; 1997 Aug; 3(3):142-9. PubMed ID: 9310191
[TBL] [Abstract][Full Text] [Related]
23. Bone marrow transplantation for chronic myeloid leukemia with volunteer unrelated donors using ex vivo or in vivo T-cell depletion: major prognostic impact of HLA class I identity between donor and recipient.
Spencer A; Szydlo RM; Brookes PA; Kaminski E; Rule S; van Rhee F; Ward KN; Hale G; Waldmann H; Hows JM; Batchelor JR; Goldman JM
Blood; 1995 Nov; 86(9):3590-7. PubMed ID: 7579468
[TBL] [Abstract][Full Text] [Related]
24. Molecular typing shows a high level of HLA class I incompatibility in serologically well matched donor/patient pairs: implications for unrelated bone marrow donor selection.
Scott I; O'Shea J; Bunce M; Tiercy JM; Argüello JR; Firman H; Goldman J; Prentice HG; Little AM; Madrigal JA
Blood; 1998 Dec; 92(12):4864-71. PubMed ID: 9845554
[TBL] [Abstract][Full Text] [Related]
25. HLA informs risk predictions after haploidentical stem cell transplantation with posttransplantation cyclophosphamide.
Fuchs EJ; McCurdy SR; Solomon SR; Wang T; Herr MR; Modi D; Grunwald MR; Nishihori T; Kuxhausen M; Fingerson S; McKallor C; Bashey A; Kasamon YL; Bolon YT; Saad A; McGuirk J; Paczesny S; Gadalla SM; Marsh SGE; Shaw BE; Spellman SR; Lee SJ; Petersdorf EW
Blood; 2022 Mar; 139(10):1452-1468. PubMed ID: 34724567
[TBL] [Abstract][Full Text] [Related]
26. Matching for HLA DPA1 and DPB1 alleles in unrelated bone marrow transplantation.
Varney MD; Lester S; McCluskey J; Gao X; Tait BD
Hum Immunol; 1999 Jun; 60(6):532-8. PubMed ID: 10408803
[TBL] [Abstract][Full Text] [Related]
27. Major-histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantation.
Petersdorf EW; Hansen JA; Martin PJ; Woolfrey A; Malkki M; Gooley T; Storer B; Mickelson E; Smith A; Anasetti C
N Engl J Med; 2001 Dec; 345(25):1794-800. PubMed ID: 11752355
[TBL] [Abstract][Full Text] [Related]
28. HLA class I (A, B, C) and class II (DRB1, DQA1, DQB1, DPB1) alleles and haplotypes in the Han from southern China.
Trachtenberg E; Vinson M; Hayes E; Hsu YM; Houtchens K; Erlich H; Klitz W; Hsia Y; Hollenbach J
Tissue Antigens; 2007 Dec; 70(6):455-63. PubMed ID: 17900288
[TBL] [Abstract][Full Text] [Related]
29. Molecular characterization of HLA-C incompatibilities in HLA-ABDR-matched unrelated bone marrow donor-recipient pairs. Sequence of two new Cw alleles (Cw*02023 and Cw*0707) and recognition by cytotoxic T lymphocytes.
Grundschober C; Rufer N; Sanchez-Mazas A; Madrigal A; Jeannet M; Roosnek E; Tiercy JM
Tissue Antigens; 1997 Jun; 49(6):612-23. PubMed ID: 9234483
[TBL] [Abstract][Full Text] [Related]
30. Pretransplant cytotoxic donor T-cell activity specific to patient HLA class I antigens correlating with mortality after unrelated BMT.
Speiser DE; Löliger CC; Siren MK; Jeannet M
Br J Haematol; 1996 Jun; 93(4):935-9. PubMed ID: 8703829
[TBL] [Abstract][Full Text] [Related]
31. Class II HLA epitope matching-A strategy to minimize de novo donor-specific antibody development and improve outcomes.
Wiebe C; Pochinco D; Blydt-Hansen TD; Ho J; Birk PE; Karpinski M; Goldberg A; Storsley LJ; Gibson IW; Rush DN; Nickerson PW
Am J Transplant; 2013 Dec; 13(12):3114-22. PubMed ID: 24164958
[TBL] [Abstract][Full Text] [Related]
32. The HLA dictionary 2001: a summary of HLA-A, -B, -C, -DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR, and -DQ antigens.
Schreuder GM; Hurley CK; Marsh SG; Lau M; Maiers M; Kollman C; Noreen HJ
Hum Immunol; 2001 Aug; 62(8):826-49. PubMed ID: 11476907
[TBL] [Abstract][Full Text] [Related]
33. Allele frequencies and haplotypic associations defined by allelic DNA typing at HLA class I and class II loci in the Japanese population.
Saito S; Ota S; Yamada E; Inoko H; Ota M
Tissue Antigens; 2000 Dec; 56(6):522-9. PubMed ID: 11169242
[TBL] [Abstract][Full Text] [Related]
34. Multiple mismatches at the low expression HLA loci DP, DQ, and DRB3/4/5 associate with adverse outcomes in hematopoietic stem cell transplantation.
Fernández-Viña MA; Klein JP; Haagenson M; Spellman SR; Anasetti C; Noreen H; Baxter-Lowe LA; Cano P; Flomenberg N; Confer DL; Horowitz MM; Oudshoorn M; Petersdorf EW; Setterholm M; Champlin R; Lee SJ; de Lima M
Blood; 2013 May; 121(22):4603-10. PubMed ID: 23596045
[TBL] [Abstract][Full Text] [Related]
35. Impact of high-resolution matching in allogeneic unrelated donor stem cell transplantation in Switzerland.
Chalandon Y; Tiercy JM; Schanz U; Gungor T; Seger R; Halter J; Helg C; Chapuis B; Gratwohl A; Tichelli A; Nicoloso de Faveri G; Roosnek E; Passweg JR; ;
Bone Marrow Transplant; 2006 May; 37(10):909-16. PubMed ID: 16565739
[TBL] [Abstract][Full Text] [Related]
36. Impact of HLA class I high-resolution mismatches on chronic graft-versus-host disease and survival of patients given hematopoietic stem cell grafts from unrelated donors.
Greinix HT; Faé I; Schneider B; Rosenmayr A; Mitterschiffthaler A; Pelzmann B; Kalhs P; Lechner K; Mayr WR; Fischer GF
Bone Marrow Transplant; 2005 Jan; 35(1):57-62. PubMed ID: 15531903
[TBL] [Abstract][Full Text] [Related]
37. High-risk HLA alleles for severe acute graft-versus-host disease and mortality in unrelated donor bone marrow transplantation.
Morishima S; Kashiwase K; Matsuo K; Azuma F; Yabe T; Sato-Otsubo A; Ogawa S; Shiina T; Satake M; Saji H; Kato S; Kodera Y; Sasazuki T; Morishima Y;
Haematologica; 2016 Apr; 101(4):491-8. PubMed ID: 26768690
[TBL] [Abstract][Full Text] [Related]
38. Clinical outcomes of HLA-DPB1 mismatches in 10/10 HLA-matched unrelated donor-recipient pairs undergoing allogeneic stem cell transplant.
Moyer AM; Hashmi SK; Kroning CM; Kremers WK; De Goey SR; Patnaik M; Litzow M; Gastineau DA; Hogan WJ; Jacob EK; Kreuter JD; Wakefield LL; Gandhi MJ
Eur J Haematol; 2017 Sep; 99(3):275-282. PubMed ID: 28632323
[TBL] [Abstract][Full Text] [Related]
39. The Case for High Resolution Extended 6-Loci HLA Typing for Identifying Related Donors in the Indian Subcontinent.
Agarwal RK; Kumari A; Sedai A; Parmar L; Dhanya R; Faulkner L
Biol Blood Marrow Transplant; 2017 Sep; 23(9):1592-1596. PubMed ID: 28603069
[TBL] [Abstract][Full Text] [Related]
40. Tacrolimus does not abrogate the increased risk of acute graft-versus-host disease after unrelated-donor marrow transplantation with allelic mismatching at HLA-DRB1 and HLA-DQB1.
Przepiorka D; Saliba R; Cleary K; Fischer H; Tonai R; Fritsche H; Khouri IF; Folloder J; Ueno NT; Mehra R; Ippoliti C; Giralt S; Gajewski J; Donato M; Claxton D; Braunschweig I; van Besien K; Anderlini P; Andersson BS; Champlin R
Biol Blood Marrow Transplant; 2000; 6(2A):190-7. PubMed ID: 10816027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
